📰 Circulatory Support News
Page 2 - Circulatory Support News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Circulatory Support. Real-time updates on events, politics, business and more.
February 22, 2023
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2022 and issued guidance for 2023.
February 22, 2023
Chennai (Tamil Nadu) [India], February 22 (ANI/NewsVoir): Kauvery Hospital Chennai, a unit of Kauvery Group of Hospitals, a leading multispecialty healthcare chain in Tamil Nadu, successfully performed a heart transplant for a 63-year-old with cardiogenic shock and a complex medical history. In a first-of-its-kind approach in India, the man was given Impella percutaneous left ventricular assist device (pVAD), to support his heart until he received a heart transplant. Impella, also known as the w...
November 2, 2022
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2022. Financial Summary and Highlights1 Revenue
September 20, 2022
Puzzle Medical Devices, a provider of hemodynamic support in Heart Failure (HF), was selected as the winner of the TCT 2022 Innovation Shark Tank Competition. The award program was held during the TCT 2022 Conference on Monday, September 19, in Boston, MA.
September 13, 2022
/PRNewswire/ -- The International Society for Heart and Lung Transplantation (ISHLT) and the European Society for Organ Transplantation (ESOT) have...
May 4, 2022
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended March 31, 2022. Financial Summary and Highlights1 Worldwide
April 14, 2022
/PRNewswire/ -- The global cardiogenic shock market was valued around US$ 3.29 Bn in 2021. By 2032, the cardiogenic shock market is slated to top US$ 6.32 Bn,...
April 14, 2022
The U.S. Accounts for Over Four-Fifth of All Cardiogenic Shock Demand Fact.MR in its latest study provides comprehensive analysis on the global cardiogenic shock market from 2022 to 2032.
February 23, 2022
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2021. For the fourth quarter of 2021
December 3, 2021
Persona Nutrition Vitamins is a personalized online vitamin and supplement program based on scientific research 2021. Check out our review to see if it is for you.